CVS Market Analysis

Overview

Fundamentals

P/E ratio59.06Forward 11.47
EPS (TTM)$1.3976.6% YoY
Profit margin0.4%HEALTHCARE
Market cap$105.21BLarge cap

Wall Street coverage

$96.58median target· current $55.97 (+72.6%)29 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
11.47
PEG ratio
0.24
P/B
1.40
P/S (TTM)
0.26
EV/EBITDA
17.70

Profitability & growth

ROE (TTM)
2.3%
Operating margin
1.6%
Revenue growth YoY
8.4%
Dividend yield
3.2%
Beta
0.51
Last earnings
Feb 10, 2026 · Estimate $1.00 · Reported $1.09
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About CVS Health Corp

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
ONE CVS DRIVE, WOONSOCKET, RI
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$105.21B
Shares outstanding$1.28B
52W high$83.93
52W low$56.29

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer